Victor F. Ganzi - 09 Feb 2021 Form 4/A - Amendment Insider Report for Angion Biomedica Corp. (ELTX)

Role: Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Victor F. Ganzi
Issuer symbol: ELTX
Transactions as of: 09 Feb 2021
Net transactions value: +$2,493
Form type: 4/A - Amendment
Filing time: 27 May 2022, 16:19:36 UTC
Date Of Original Report: 11 Feb 2021
Next filing: 13 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Exercise of in-the-money or at-the-money derivative security	$3,950,013	+614,310	+135%	$6.43	1,069,837	09 Feb 2021	Direct
transaction	ELTX	Common Stock	Sale	$3,947,520	-246,720	-23%	$16.00	823,117	09 Feb 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Warrant to Purchase Common Stock	Exercise of in-the-money or at-the-money derivative security	$0	-614,310	-100%	$0.000000^*	0	09 Feb 2021	Common Stock	614,310	$6.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.